Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects.

Autor: Romito, Ilaria1 (AUTHOR), Porru, Manuela2 (AUTHOR), Braghini, Maria Rita1 (AUTHOR), Pompili, Luca2 (AUTHOR), Panera, Nadia1 (AUTHOR), Crudele, Annalisa1 (AUTHOR), Gnani, Daniela3 (AUTHOR), De Stefanis, Cristiano4 (AUTHOR), Scarsella, Marco4 (AUTHOR), Pomella, Silvia5 (AUTHOR), Mortera, Stefano Levi6 (AUTHOR), de Billy, Emmanuel5 (AUTHOR), Conti, Adrian Libenzio4 (AUTHOR), Marzano, Valeria6 (AUTHOR), Putignani, Lorenza6,7 (AUTHOR), Vinciguerra, Manlio8,9 (AUTHOR), Balsano, Clara10,11 (AUTHOR), Pastore, Anna12 (AUTHOR), Rota, Rossella5 (AUTHOR), Tartaglia, Marco13 (AUTHOR)
Zdroj: Journal of Experimental & Clinical Cancer Research (17569966). 1/27/2022, Vol. 41 Issue 1, p1-6. 6p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje